Seeing Is Believing
Currently out of the existing stock ratings of Jonathan Yong, 64 are a BUY (42.95%), 76 are a HOLD (51.01%), 9 are a SELL (6.04%).
Analyst Jonathan Yong, currently employed at UBS, carries an average stock price target met ratio of 65.73% that have a potential upside of 19.09% achieved within 199 days. Previously, Jonathan Yong worked at CREDIT SUISSE, STIFEL.
Jonathan Yong’s has documented 303 price targets and ratings displayed on 34 stocks. The coverage is on Healthcare, Financial Services, Consumer Defensive sectors.
Most recent stock forecast was given on CLOV, Clover Health Investments Corp at 11-Jun-2026.
Analyst best performing recommendations are on CLOV (CLOVER HEALTH INVESTMENTS CORP).
The best stock recommendation documented was for CLOV (CLOVER HEALTH INVESTMENTS CORP) at 8/9/2022. The price target of $3 was fulfilled within 1 day with a profit of $0.21 (7.53%) receiving and performance score of 75.27.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 07-May-2026
$35
$5.21 (17.49%)
$30
28 days ago
(10-Jun-2026)
5/7 (71.43%)
$7.15 (25.67%)
102
Sell Since 07-Oct-2025
$20
$-9.79 (-32.86%)
$11
1 months 4 days ago
(04-Jun-2026)
6/9 (66.67%)
$-3.6 (-15.25%)
562
Hold Since 07-May-2026
$19
$-10.79 (-36.22%)
$14
2 months 1 days ago
(07-May-2026)
2/3 (66.67%)
$-1.87 (-8.96%)
48
Sell Since 10-Jul-2025
$16
$-13.79 (-46.29%)
$9
2 months 18 days ago
(20-Apr-2026)
1/3 (33.33%)
$-0.44 (-2.68%)
119
Sell Since 07-Nov-2025
$17
$-12.79 (-42.93%)
$12
5 months 29 days ago
(09-Jan-2026)
9/9 (100%)
$-0.73 (-4.12%)
363
Which stock is Jonathan Yong is most bullish on?
What Year was the first public recommendation made by Jonathan Yong?